1459 related articles for article (PubMed ID: 9500758)
41. Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5.
Madritsch C; Flicker S; Scheiblhofer S; Zafred D; Pavkov-Keller T; Thalhamer J; Keller W; Valenta R
Clin Exp Allergy; 2011 Feb; 41(2):270-80. PubMed ID: 21143538
[TBL] [Abstract][Full Text] [Related]
42. Phleum pratense-specific T cells of allergic rhinitis patients display a broader recognition pattern than phleum pratense-specific serum immunoglobulin E.
Van Neerven RJ; Arnved J; Ipsen H
Clin Exp Allergy; 2000 Feb; 30(2):242-54. PubMed ID: 10651777
[TBL] [Abstract][Full Text] [Related]
43. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
44. Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients.
Moreira PF; Gangl K; Vieira Fde A; Ynoue LH; Linhart B; Flicker S; Fiebig H; Swoboda I; Focke-Tejkl M; Taketomi EA; Valenta R; Niederberger V
PLoS One; 2015; 10(6):e0128402. PubMed ID: 26067084
[TBL] [Abstract][Full Text] [Related]
45. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens.
Canis M; Gröger M; Becker S; Klemens C; Kramer MF
Am J Rhinol Allergy; 2011; 25(1):36-9. PubMed ID: 21711974
[TBL] [Abstract][Full Text] [Related]
46. How far can we simplify in vitro diagnostics for grass pollen allergy?: A study with 17 whole pollen extracts and purified natural and recombinant major allergens.
van Ree R; van Leeuwen WA; Aalberse RC
J Allergy Clin Immunol; 1998 Aug; 102(2):184-90. PubMed ID: 9723659
[TBL] [Abstract][Full Text] [Related]
47. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
[TBL] [Abstract][Full Text] [Related]
48. Relationship between Bet v 1 and Bet v 2 specific IgE and food allergy in children with grass pollen respiratory allergy.
Ricci G; Righetti F; Menna G; Bellini F; Miniaci A; Masi M
Mol Immunol; 2005 Jun; 42(10):1251-7. PubMed ID: 15829314
[TBL] [Abstract][Full Text] [Related]
49. Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy.
Archila LD; DeLong JH; Wambre E; James EA; Robinson DM; Kwok WW
Clin Exp Allergy; 2014 Jul; 44(7):986-98. PubMed ID: 24708411
[TBL] [Abstract][Full Text] [Related]
50. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
[TBL] [Abstract][Full Text] [Related]
51. Glycoproteins are species-specific markers and major IgE reactants in grass pollens.
Manduzio H; Fitchette AC; Hrabina M; Chabre H; Batard T; Nony E; Faye L; Moingeon P; Gomord V
Plant Biotechnol J; 2012 Feb; 10(2):184-94. PubMed ID: 21951299
[TBL] [Abstract][Full Text] [Related]
52. Expression of a major plant allergen as membrane-anchored and secreted protein in human cells with preserved T cell and B cell epitopes.
Baranyi U; Gattringer M; Boehm A; Marth K; Focke-Tejkl M; Bohle B; Blatt K; Valent P; Valenta R; Wekerle T
Int Arch Allergy Immunol; 2011; 156(3):259-66. PubMed ID: 21720171
[TBL] [Abstract][Full Text] [Related]
53. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE.
Niederberger V; Laffer S; Fröschl R; Kraft D; Rumpold H; Kapiotis S; Valenta R; Spitzauer S
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):258-64. PubMed ID: 9500760
[TBL] [Abstract][Full Text] [Related]
54. Antigens drive memory IgE responses in human allergy via the nasal mucosa.
Niederberger V; Ring J; Rakoski J; Jager S; Spitzauer S; Valent P; Horak F; Kundi M; Valenta R
Int Arch Allergy Immunol; 2007; 142(2):133-44. PubMed ID: 17057411
[TBL] [Abstract][Full Text] [Related]
55. Clinical allergy to hazelnut and peanut: identification of T cell cross-reactive allergens.
Glaspole IN; de Leon MP; Prickett SR; O'Hehir RE; Rolland JM
Int Arch Allergy Immunol; 2011; 155(4):345-54. PubMed ID: 21346364
[TBL] [Abstract][Full Text] [Related]
56. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.
Ebner C; Siemann U; Bohle B; Willheim M; Wiedermann U; Schenk S; Klotz F; Ebner H; Kraft D; Scheiner O
Clin Exp Allergy; 1997 Sep; 27(9):1007-15. PubMed ID: 9678832
[TBL] [Abstract][Full Text] [Related]
57. T cell response to grass pollen allergens: correlation with skin test reactivity and serum IgE levels.
Blaher B; McCluskey J; Puy R; Czarny D; Rolland JM
Immunol Cell Biol; 1995 Feb; 73(1):17-22. PubMed ID: 7768540
[TBL] [Abstract][Full Text] [Related]
58. Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy.
Chabre H; Gouyon B; Huet A; Baron-Bodo V; Nony E; Hrabina M; Fenaille F; Lautrette A; Bonvalet M; Maillère B; Bordas-Le Floch V; Van Overtvelt L; Jain K; Ezan E; Batard T; Moingeon P
Clin Exp Allergy; 2010 Mar; 40(3):505-19. PubMed ID: 19895591
[TBL] [Abstract][Full Text] [Related]
59. IgE cross-reactivity between meadow fescue pollen and kiwi fruit in patients' sera with sensitivity to both extracts.
Gavrović-Jankulović M; Cirković T; Burazer L; Vucković O; Jankov RM
J Investig Allergol Clin Immunol; 2002; 12(4):279-86. PubMed ID: 12926188
[TBL] [Abstract][Full Text] [Related]
60. Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity.
Linhart B; Jahn-Schmid B; Verdino P; Keller W; Ebner C; Kraft D; Valenta R
FASEB J; 2002 Aug; 16(10):1301-3. PubMed ID: 12154002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
